| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |